171 results
Page 2 of 9
CORRESP
ejob1l h698nzk62tkt
17 Nov 23
Correspondence with SEC
12:00am
8-K
EX-99.2
n9cdd
18 Aug 23
Regulation FD Disclosure
5:16pm
424B5
y0a hxbnd1cgjo
11 Jul 23
Prospectus supplement for primary offering
5:08pm
8-K
EX-1.1
dxp2eq 94j
11 Jul 23
Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock
4:55pm
424B5
2koetgij07i6
10 Jul 23
Prospectus supplement for primary offering
5:27pm
8-K
EX-3.1
mzar5 3hn
10 Jul 23
Results of Operations and Financial Condition
4:40pm
8-K
EX-1.1
yqflt94l6podz
16 Jun 23
Entry into a Material Definitive Agreement
4:51pm
S-3ASR
EX-4.1
2ktjx62i7w ckgh3
16 Jun 23
Automatic shelf registration
4:11pm
S-8
EX-99.1
koriy yjzu
12 Jun 23
Registration of securities for employees
4:31pm
8-K/A
EX-99.3
9ip4ud8 0tfsplhir
2 Jun 23
Financial Statements and Exhibits
4:30pm
8-K/A
EX-99.1
7ih0o57y
2 Jun 23
Financial Statements and Exhibits
4:30pm
8-K/A
EX-99.2
a0lu wo9t2531
2 Jun 23
Financial Statements and Exhibits
4:30pm
8-K
EX-99.1
wo0jk
9 May 23
Iovance Biotherapeutics Reports First Quarter 2023
4:05pm